News

Filter

1 to 9 of 195 results

Immune Pharmaceuticals appoints Paul Nadler as acting executive VP of R&D and CMO

Immune Pharmaceuticals appoints Paul Nadler as acting executive VP of R&D and CMO

09-02-2015

Israel-based Immune Pharmaceuticals has appointed Paul Nadler as acting executive vice president of research…

BoardroomImmune PharmaceuticalsImmunologicalsIsraelPharmaceutical

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

28-01-2015

Vienna-based allergy immunotherapy specialist Biomay has successfully completed a Phase IIb study of…

BiomayBM32ImmunologicalsPharmaceuticalResearchSwitzerland

ALK's partner Torii submits NDA in Japan for house dust mite sublingual tablet

ALK's partner Torii submits NDA in Japan for house dust mite sublingual tablet

26-01-2015

Denmark-based allergy specialist ALK Abello’s Japanese partner, Torii Pharmaceutical, has submitted…

ALK AbelloImmunologicalsJapanPharmaceuticalRegulationSLIT-tabletTorii Pharma

Boehringer Ingelheim enters research pact with Yale University

Boehringer Ingelheim enters research pact with Yale University

14-01-2015

German family-owned pharma major Boehringer Ingelheim has entered into a collaboration with Yale University,…

Boehringer IngelheimGermanyImmunologicalsOncologyPharmaceuticalResearchRespiratory and Pulmonary

Link between immune system and brain diseases to be researched by Lundbeck

22-12-2014

Danish CNS specialist drugmaker Lundbeck is involved in new groundbreaking research that will investigate…

ImmunologicalsJanssenLundbeckNeurologicalPharmaceuticalResearch

ADMA’s lead product meets primary endpoint in Phase III trial

04-12-2014

US-based biopharmaceutical company ADMA Biologics says that its lead product candidate RI-002 has demonstrated…

ADMA BiologicsImmunologicalsPharmaceuticalResearchRI-002USA

GlaxoSmithKline drops option for Dynavax’ DV1179

28-11-2014

USA-based Dynavax Technologies (Nasdaq: DVAX) today announced that it has regained full rights to DV1179,…

DV1179Dynavax TechnologiesGlaxoSmithKlineImmunologicalsLicensingPharmaceuticalResearch

ALK Abello files for European approval for its dust mite allergy sublingual tablets

ALK Abello files for European approval for its dust mite allergy sublingual tablets

20-11-2014

Denmark-based allergy specialist ALK Abello has filed a registration application for its house dust mite…

ALK AbelloDenmarkImmunologicalsPharmaceuticalRegulation

1 to 9 of 195 results

COMPANY SPOTLIGHT

Menarini

Back to top